When you stop taking a GLP-1, and these mechanisms no longer work, you are likely to eat more, which can lead to weight gain
A detailed study of 55,460 non-diabetic patients revealed gastroparesis rates of 6.5 per 1000 person-years in semaglutide users
NICE guidelines support Wegovy use for weight management in adults with a BMI of at least 35 (or 30 with weight-related health conditions) alongside a supervised weight management programme
One is that obviously their patients are losing weight, so theres a physical and mechanical aspect, but also theres something about semaglutide that also has an anti-inflammatory (effect). Bert Mandelbaum, MD Its not proven in this study, but there have been other studies that show that (semaglutide) reduces cardiovascular risks
The main physiological function of L-carnitine for athletes is to promote the conversion of fat into energy